MDCPX
Price
$27.30
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
RLBGX
Price
$36.66
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

MDCPX vs RLBGX

Header iconMDCPX vs RLBGX Comparison
Open Charts MDCPX vs RLBGXBanner chart's image
BlackRock Sustainable Balanced Inv A
Price$27.30
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
American Funds American Balanced R6
Price$36.66
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
MDCPX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MDCPX vs. RLBGX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDCPX is a StrongBuy and RLBGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RLBGX has more cash in the bank: 240B vs. MDCPX (1.66B). RLBGX (2.55) and MDCPX (2.50) have matching dividends . MDCPX was incepted earlier than RLBGX: MDCPX (30 years) vs RLBGX (16 years). RLBGX is a more actively managed with annual turnover of: 171.00 vs. MDCPX (152.00). RLBGX has a lower initial minimum investment than MDCPX: RLBGX (250) vs MDCPX (1000). RLBGX annual gain was more profitable for investors over the last year : 23.04 vs. MDCPX (20.82). RLBGX return over 5 years is better than : 38.63 vs. MDCPX (23.74).
MDCPXRLBGXMDCPX / RLBGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years16 years-
Gain YTD13.74415.93586%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.66B240B1%
Annual Yield % from dividends2.502.5598%
Returns for 1 year20.8223.0490%
Returns for 3 years-2.5212.77-20%
Returns for 5 years23.7438.6361%
Returns for 10 years18.2356.1032%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RARE48.720.88
+1.84%
Ultragenyx Pharmaceutical
BCS13.21-0.01
-0.08%
Barclays PLC
PUBM16.27-0.15
-0.94%
PubMatic
MRKR3.64-0.08
-2.15%
Marker Therapeutics
EDAP2.55-0.09
-3.41%
EDAP TMS SA